These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9053804

  • 1. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect reversed by naloxone.
    Yu LC, Hansson P, Lundeberg T.
    Neuroscience; 1996 Mar; 71(2):523-31. PubMed ID: 9053804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Opioid antagonists naloxone, beta-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37.
    Yu LC, Hansson P, Lundeberg T.
    Brain Res; 1995 Nov 06; 698(1-2):23-9. PubMed ID: 8581488
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats.
    Yu LC, Hansson P, Lundeberg T.
    Brain Res; 1994 Aug 08; 653(1-2):223-30. PubMed ID: 7526959
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of calcitonin gene-related peptide-(8-37) on withdrawal responses in rats with inflammation.
    Yu LC, Hansson P, Lundeberg S, Lundeberg T.
    Eur J Pharmacol; 1998 Apr 24; 347(2-3):275-82. PubMed ID: 9653894
    [Abstract] [Full Text] [Related]

  • 10. Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems.
    Ma W, Chabot JG, Powell KJ, Jhamandas K, Dickerson IM, Quirion R.
    Neuroscience; 2003 Apr 24; 120(3):677-94. PubMed ID: 12895509
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of intrathecal galanin on nociceptive responses in rats with mononeuropathy.
    Yu LC, Lundeberg S, An H, Wang FX, Lundeberg T.
    Life Sci; 1999 Apr 24; 64(13):1145-53. PubMed ID: 10210277
    [Abstract] [Full Text] [Related]

  • 13. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
    Trang T, Ma W, Chabot JG, Quirion R, Jhamandas K.
    Pain; 2006 Dec 15; 126(1-3):256-71. PubMed ID: 16935424
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
    Collin E, Frechilla D, Pohl M, Bourgoin S, Le Bars D, Hamon M, Cesselin F.
    Brain Res; 1993 Apr 23; 609(1-2):211-22. PubMed ID: 8389648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.